USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Biotronik SE & Co. KG

USPTO PatentsView assignee record - 266 granted patents across 63 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

RSS updates for this company

The verdict

According to USPTO PatentsView, Biotronik ranks #1,557 of 49,997 tracked US assignees by granted-patent volume, with 266 patents across 63 technology areas.

#1,557
of 49,997 US assignees by volume
Top 3%
by Innovation Score (60.2/100)
14.3
avg claims per patent
-8%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1557 · Foreign Corporation #1,557 · 266 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-MID 266 grants
  • TOP-DECILE #1,557/49,997
  • PHOTO-FINISH Eisai R&D Management
  • CPC-WIDE A61N · 63 areas
  • INNOV-STRONG 60.2/100
  • CLAIMS-RICH 14.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-FLAT -8% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Eisai R&D Management Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Biotronik

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Biotronik's Innovation Score is 60.2/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

How Biotronik's grant cadence moved

Between 2020–2024, Biotronik SE & Co. KG received 119 grants versus 129 in 2015–2019 (-8% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2016 at 42 grants and bottomed in 2024 at 14. Lead class A61N accounts for 82.3% of the portfolio across 63 subclasses. Volume neighbours: Fujitsu TEN Limited (#1,553) and Tenneco Automotive Operating Company LLC (#1,561).

Biotronik's three-year grant acceleration

From 2019–2021 to 2022–2024, Biotronik SE & Co. KG moved from 67 to 74 grants (1.10x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #951. See the growth leaderboard.

Who files at Biotronik's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Biotronik holds 266 patents at rank #1,557, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Biotronik

By rank, the assignees closest to #1,557 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Biotronik's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Biotronik, neither rank-band nor same-CPC leaders (those blocks stay above).

Biotronik's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

60 Top 3% higher than 97% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

1020304050 20152016201720182019202020212022202320242025 18
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Biotronik SE & Co. KG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 26 9.8%
2016 42 15.8%
2017 20 7.5%
2018 19 7.1%
2019 22 8.3%
2020 21 7.9%
2021 24 9.0%
2022 28 10.5%
2023 32 12.0%
2024 14 5.3%
2025partial year 18 6.8%

Which technologies does Biotronik SE & Co. KG patent most?

Top 15 of 63 technology areas

Where it ranks

Overall rank by patents

#1,557

of 49,997 tracked assignees

Innovation Score

60.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Biotronik SE & Co. KG's patent record in context - here's where to go next.

  • Biotronik SE & Co. KG's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 82.3% of its portfolio - see every assignee active in that class. Explore A61N
  • Ranked #1,557 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Biotronik SE & Co. KG against Fujitsu TEN Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 60.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.